Opaleye Management »

Newamsterdam Pharma Co Nv shares owned by Opaleye Management

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by Opaleye Management from 13F filings

Historical chart of Opaleye Management investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by Opaleye Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by Opaleye Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.0M 265k 11.17

More positions owned by Opaleye Management

Harrow Health (HROW)
Tg Therapeutics (TGTX)
Acelyrin (SLRN)
Rhythm Pharmaceuticals (RYTM)
Ocular Therapeutix (OCUL)
Catalyst Pharmaceutical Partners (CPRX)
Keros Therapeutics (KROS)
Ideaya Biosciences (IDYA)
Eton Pharmaceuticals (ETON)
Crinetics Pharmaceuticals In (CRNX)
Arvinas Ord (ARVN)
Codexis (CDXS)
Biohaven (BHVN)
Edgewise Therapeutics (EWTX)
Iovance Biotherapeutics (IOVA)

View all positions for Opaleye Management

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
Fcpm Iii Services B.v.
Viking Global Investors
RA Capital Management
Medicxi Ventures Management
BVF
Goldman Sachs Group
GMT Capital Corp
Millennium Management
Alyeska Investment Group
Opaleye Management
Schonfeld Strategic Advisors
Marshall Wace
Yarbrough Capital
HealthInvest Partners AB

View all funds holding Newamsterdam Pharma Co Nv